Bt. Teh et al., MUTATION ANALYSIS OF THE MEN1 GENE IN MULTIPLE ENDOCRINE NEOPLASIA TYPE-1, FAMILIAL ACROMEGALY AND FAMILIAL ISOLATED HYPERPARATHYROIDISM, The Journal of clinical endocrinology and metabolism, 83(8), 1998, pp. 2621-2626
Multiple endocrine neoplasia type 1 (MEN 1) is an autosomal dominant d
isease characterized by neoplasia of the parathyroid glands, the endoc
rine pancreas, and the anterior pituitary gland. In addition, families
with isolated endocrine neoplasia, notably familial isolated hyperpar
athyroidism (FIHP) and familial acromegaly, have also been reported. H
owever, whether these families constitute MEN 1 variants or separate e
ntities remains speculative as the genetic bases for these diseases ar
e unclear. The gene for MEN 1 has recently been cloned and characteriz
ed. Using single strand conformation analysis (SSCA) and sequencing, w
e performed mutation analysis in: a) a total of 55 MEN 1 families from
7 countries, b) 13 isolated MEN 1 cases without family history of the
disease, c) 8 acromegaly families, and d) 4 FIHP families. Mutations
were identified in 27 MEN 1 families and 9 isolated cases. The 22 diff
erent mutations spread across most of the 9 translated exons and inclu
ded frameshift (11), nonsense (6), splice (2), missense mutations (2),
and in-frame deletions (1). Among the 19 Finnish MEN 1 probands, a 14
66del12 mutation was identified in 6 families with identical 11q13 hap
lotypes and in 2 isolated cases indicating a common founder. One frame
shift mutation caused by 359del4 (GTCT) was found in 1 isolated case a
nd 4 kindreds of different origin and haplotypes; this mutation theref
ore represents a common ''warm'' spot in the MEN 1 gene. By analyzing
the DNA of the parents of an isolated case one mutation was confirmed
to be de novo. No mutation was found in any of the acromegaly and smal
l FIHP families, suggesting that genetic defects other than the MEN 1
gene might be involved and that additional such families need to be an
alyzed.